Luminoah, Inc. — SEC Form D Filing
Luminoah, Inc. filed an SEC Form D on November 6, 2026, reporting $25.41M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- November 6, 2026
- Amount reported
- $25.41M
- Round stage
- Series A
- Industry
- Medical Devices
- Website
- https://luminoah.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Individuals who rely on enteral nutrition (tube feeding) typically face restrictive and cumbersome equipment, often leaving them tethered to IV poles or forced to carry bulky backpacks.
Solution
Luminoah developed Luminoah Flow, a compact and lightweight enteral feeding system featuring a wearable pump, an intuitive touchscreen, and a companion mobile app for real-time tracking and delivery management.
Why now
Advances in hardware miniaturization, battery density, and mobile connectivity enable traditional institutional medical devices to shift into portable, patient-friendly home-use form factors.
Verdict
Luminoah secured $25M because investors saw an immediate consumerization wedge in a stagnant, highly concentrated reimbursement category, betting that miniaturized hardware and connected compliance data could wrest prescription share from entrenched hospital-grade incumbents. This cleared because it packaged proven enteral nutrition reimbursement codes into an undeniably superior ambulatory patient experience, not because the underlying delivery mechanism possessed deep technological defensibility. Upside is structurally constrained by durable medical equipment distributor margins and the friction of unseating legacy players from institutional discharge formularies.
Source: SEC EDGAR Form D filing